Aytu Biopharma (AYTU) Short-term Investments (2016 - 2021)

Aytu Biopharma (AYTU) has 6 years of Short-term Investments data on file, last reported at $252000.0 in Q3 2021.

• On a quarterly basis, Short-term Investments changed 0.0% year-over-year to $252000.0 in Q3 2021; TTM through Sep 2021 was $252000.0, a 0.0% change from a year earlier, with the FY2021 full-year figure at $252000.0, changed 0.4% from the prior year.
• Short-term Investments for Q3 2021 stood at $252000.0, roughly flat from $252000.0 in the prior quarter.
• Over the last five years, Short-term Investments for AYTU reached as high as $252000.0 in Q3 2020 and fell as low as $75214.0 in Q2 2017.
• Historically, Short-term Investments has averaged $195549.0 across 5 years, with a median of $250500.0 in 2019.
• Across the five-year window, Short-term Investments plunged 92.78% in 2017 and soared 150.83% in 2019, its largest moves.
• Year by year, Short-term Investments stood at $75214.0 in 2017, then soared by 33.25% to $100225.0 in 2018, then surged by 150.83% to $251396.0 in 2019, then advanced by 0.24% to $252000.0 in 2020, then changed by 0.0% to $252000.0 in 2021.
• Per Business Quant data, the three most recent Short-term Investments figures were $252000.0 in Q3 2021, $252000.0 in Q2 2021, and $252000.0 in Q4 2020.